ACTRN12622001280796尚未招募1 期
A double-blind, placebo controlled randomised study to assess the tolerability, safety, and preliminary efficacy of taurolidine-citrate lock solution (TauroLock™) in patients with recurrent pleural effusions requiring management with Indwelling Pleural Catheters for recurrent effusion drainage.
St John of God Midland Hospital0 个研究点目标入组 18 人开始时间: 2022年9月29日最近更新:
试验速览
- 阶段
- 1 期
- 状态
- 尚未招募
- 发起方
- 入组人数
- 18
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomised controlled trial
- 主要目的
- Prevention
- 盲法
- Blinded (masking used)
入排标准
- 年龄范围
- 18 Years 至 o limit（—）
- 性别
- All
入选标准
- •1. Patients with an Indwelling Pleural Catheter (IPC) for recurrent pleural effusion who consent to the trial.
- •2. Must be within community nursing service catchment (e.g. Silver Chain) and be able to attend follow up appointments at SJOG Midland as required.
排除标准
- •1. Patients unable to provide informed consent
- •2. Life expectancy <3 months
- •3. Known adverse reaction to taurolidine or citrate
- •4. Patient requiring other intrapleural medication
- •5. Active bleeding of sufficient severity to warrant hospital admission or withholding of regular anticoagulation therapy
- •6. Severe renal impairment (eGFR <30)
- •7. Concurrent pregnancy, lactation
- •8. Patients with previous documented pleural infection within 6 months
- •9. Uncontrolled pain at baseline
研究者
相似试验
进行中（未招募）
不适用
A study to assess the safety and effectiveness of the antipsychotic medication risperidone in the treatment of children and adolescents with the psychiatric diagnosis conduct disorder - which is characterised by persistent aggressive and antisocial behaviour - by comparing it to treatment with a non-active substance. Patients will be randomly allocated to treatment with the active- or the non-active substance.Conduct Disorder (DSM-IV-TR312.8xAmerican Psychiatric Association)MedDRA version: 16.0Level: PTClassification code 10064478Term: Conduct disorderSystem Organ Class: 10037175 - Psychiatric disordersEUCTR2011-000567-26-DERadboud University Medical Centre Nijmegen264
进行中（未招募）
1 期
a study of menthol for pain relief during photodynamic therapyActinic keratosis (pre-cancerous sun damage)on the face and scalpMedDRA version: 20.0 Level: PT Classification code 10000614 Term: Actinic keratosis System Organ Class: 10040785 - Skin and subcutaneous tissue disordersEUCTR2015-002849-59-GBniversity of Dundee30
进行中（未招募）
不适用
A double-blind, randomised placebo controlled study of the effects of Acarbose on endothelial function, hemostatic and fibrinolytic plasmatic factors in patients with stable coronary artery disease and either impaired glucose intolerance or newly diagnosed diabetes mellitus1. To study the effect of Acarbose treatment on endothelial function as a potential mechanism for the beneficial effects of better postprandial glycemic control in patients with impaired glucose tolerance or newly diagnosed diabetes mellitusEUCTR2004-002579-17-DEMedizinische Klinik B, Herzzentrum Ludwigshafen
招募中
3 期
The effect of using Growth Hormone in Invitro Fertilisation on livebirth ratesinfertilityACTRN12609001060235Robinson Institute389
进行中（未招募）
不适用
A randomised, double blind placebo controlled study in patients with reflux symptoms to assess suppression of gastro-oesophageal reflux by ‘Gaviscon Double Action Peppermint liquid’ using the BRAVO system - Gaviscon Double Action vs placebo studyEUCTR2010-021630-63-GBReckitt Benckiser40